Many people who remain persistently seronegative despite frequent HIV exposure have HIV-specific immune responses. The study of these may provide information about mechanisms of natural protective immunity to HIV-1. We describe the specificity of cytotoxic T lymphocyte responses to HIV in seronegative prostitutes in Nairobi who are apparently resistant to HIV infection. These women have had frequent exposure to a range of African HIV-1 variants, primarily clades A, C, and D, for up to 12 yr without becoming infected. Nearly half of them have CTL directed towards epitopes previously defined for B clade virus, which are largely conserved in the A and D clade sequences. Stronger responses are frequently elicited using the A or D clade version of an epitope to stimulate CTL, suggesting that they were originally primed by exposure to these virus strains. CTL responses have been defined to novel epitopes presented by HLA class I molecules associated with resistance to infection in the cohort, HLA-A*6802 and HLA-B18. Estimates using a modified interferon-gamma Elispot assay indicate a circulating frequency of CTL to individual epitopes of between 1:3,200 and 1:50,000. Thus, HIV-specific immune responses-particularly cross-clade CTL activity- may be responsible for protection against persistent HIV infection in these African women.
S L Rowland-Jones, T Dong, K R Fowke, J Kimani, P Krausa, H Newell, T Blanchard, K Ariyoshi, J Oyugi, E Ngugi, J Bwayo, K S MacDonald, A J McMichael, F A Plummer
Title and authors | Publication | Year |
---|---|---|
Late seroconversion in HIV-1 "resistant" prostitutes despite pre-existing HIV-1 specific CD8+ responses: association with reduced HIV exposure
Rupert Kaul, Sarah L. Rowland-Jones, Joshua Kimani, Tao Dong, Hong-Bing Yang, Peter Kiama, Timothy Rostron, Ephantus Njagi, Job J. Bwayo, Kelly S. MacDonald, Andrew J. McMichael, Francis A. Plummer |
Journal of Clinical Investigation | 2001 |
HIV specific CD8+ lymphocyte responses correlate with resistance to HIV infection, and target different epitopes in seronegative and infected subjects
Rupert Kaul, Tao Dong, Francis A. Plummer, Joshua Kimani, Timothy Rostron, Peter Kiama, Ephantus Njagi, Erastus Irungu, Bashir Farah, Julius Oyugi, Rana Chakraborty, Kelly S. MacDonald, Job J. Bwayo, Andrew McMichael, Sarah L. Rowland-Jones |
Journal of Clinical Investigation | 2001 |
The realistic hope for curbing the expanding HIV pandemic
Norman Letvin, Bruce D. Walker |
Journal of Clinical Investigation | 2001 |
Cellular immune responses to HIV
AJ McMichael, SL Rowland-Jones |
Nature | 2001 |
The influence of HLA genotype on AIDS
M Carrington, SJ O'Brien |
Annual Review of Medicine | 2001 |
Current Protocols in Immunology
EH Leiter |
Current Protocols in Immunology | 2001 |
Perspectives on inducing efficient immune control of HIV-1 replication - a new goal for HIV therapeutics?
RP Bucy, JM Kilby |
AIDS | 2001 |
Directex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection
AM Grabowska, F Lechner, P Klenerman, PJ Tighe, S Ryder, JK Ball, BJ Thomson, WL Irving, RA Robins |
European Journal of Immunology | 2001 |
Human Immunodeficieny Virus Pathogenesis and Prospects for Immune Control in Patients with Established Infection
DE Cohen, BD Walker |
Clinical Infectious Diseases | 2001 |
Detection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCV
DK Wong, DD Dudley, PB Dohrenwend, GM Lauer, RT Chung, DL Thomas, BD Walker |
Journal of virology | 2001 |
Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design
V Novitsky, N Rybak, MF McLane, P Gilbert, P Chigwedere, I Klein, S Gaolekwe, SY Chang, T Peter, I Thior, T Ndung'u, F Vannberg, BT Foley, R Marlink, TH Lee, M Essex |
Journal of virology | 2001 |
Rabies virus-based vectors expressing human immunodeficiency virus type 1 (HIV-1) envelope protein induce a strong, cross-reactive cytotoxic T-lymphocyte response against envelope proteins from different HIV-1 isolates
JP McGettigan, HD Foley, IM Belyakov, JA Berzofsky, RJ Pomerantz, MJ Schnell |
Journal of virology | 2001 |
Construction and in vitro properties of a series of attenuated simian immunodeficiency viruses with all accessory genes deleted
Y Guan, JB Whitney, M Detorio, MA Wainberg |
Journal of virology | 2001 |
Failure to detect HLA-A*6802-restricted CD8+ T cells specific for Chlamydia trachomatis antigens in subjects from trachoma-endemic communities
OS Mahdi, HC Whittle, H Joof, DC Mabey, RL Bailey |
Clinical & Experimental Immunology | 2001 |
Mature dendritic cells infected with canarypox virus elicit strong anti-human immunodeficiency virus CD8+ and CD4+ T-cell responses from chronically infected individuals
J Engelmayer, M Larsson, A Lee, M Lee, WI Cox, RM Steinman, N Bhardwaj |
Journal of virology | 2001 |
HIV-Specific Cytotoxic T Lymphocytes, HLA-A11, and Chemokine-Related Factors May Act Synergistically to Determine HIV Resistance in CCR5 Δ32-Negative Female Sex Workers in Chiang Rai, Northern Thailand
B Sriwanthana, T Hodge, TD Mastro, CS Dezzutti, K Bond, HA Stephens, LG Kostrikis, K Limpakarnjanarat, NL Young, SH Qari, RB Lal, D Chandanayingyong, JM McNicholl |
AIDS Research and Human Retroviruses | 2001 |
High Levels of CD8-Positive Lymphocytes Expressing CD45R0, Granzyme B, and Ki-67 in Lymph Nodes of HIV-Infected Individuals Are Not Associated with Increased Mortality
C Espersen, B Pakkenberg, E Harder, G Pallesen, J Gerstoft, BK Pedersen, H Ullum |
AIDS Research and Human Retroviruses | 2001 |
Human leucocyte antigen supertypes and immune susceptibility to HIV-1, implications for vaccine design
KS MacDonald, L Matukas, JE Embree, K Fowke, J Kimani, NJ Nagelkerke, J Oyugi, P Kiama, R Kaul, MA Luscher, S Rowland-Jones, J Ndinya-Achola, E Ngugi, JJ Bwayo, FA Plummer |
Immunology Letters | 2001 |
Characterization of High-Risk HIV-1 Seronegative Hemophiliacs
JR Salkowitz, SF Purvis, H Meyerson, P Zimmerman, TR O'Brien, L Aledort, ME Eyster, M Hilgartner, C Kessler, BA Konkle, GC White, JJ Goedert, MM Lederman |
Clinical Immunology | 2001 |
A simple and efficient method for the monitoring of antigen-specific T cell responses using peptide pool arrays in a modified ELISpot assay
TW Tobery, S Wang, XM Wang, MP Neeper, KU Jansen, WL McClements, MJ Caulfield |
Journal of Immunological Methods | 2001 |
Recent developments in human HIV-1 vaccine
D Dabelstein, B Cromer |
Family Practice | 2001 |
DNA Vaccination of Macaques with Several Different Nef Sequences Induces Multispecific T Cell Responses
I Couillin, F Letourneur, P Lefèbvre, JG Guillet, F Martinon |
Virology | 2001 |
Mucosal Exposure to Subinfectious Doses of SIV Primes Gut-Associated Antibody-Secreting Cells and T Cells: Lack of Enhancement by Nonneutralizing Antibody
N Polyanskaya, LA Bergmeier, SA Sharpe, N Cook, S Leech, G Hall, M Dennis, P Haaft, J Heeney, F Manca, T Lehner, MP Cranage |
Virology | 2001 |
Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers
K Broliden, J Hinkula, C Devito, P Kiama, J Kimani, D Trabbatoni, JJ Bwayo, M Clerici, F Plummer, R Kaul |
Immunology Letters | 2001 |
HIV in the Female Genital Tract: Viral Shedding and Mucosal Immunity:
L Al-Harthi, A Landay |
Clinical Obstetrics and Gynecology | 2001 |
Challenges and opportunities for development of an AIDS vaccine
GJ Nabel |
Nature | 2001 |
How important is the 'quality' of the cytotoxic T lymphocyte (CTL) response in protection against HIV infection?
S L Rowland-Jones, S Pinheiro, R Kaul, P Hansasuta, G Gillespie, T Dong, F A Plummer, J B Bwayo, S Fidler, J Weber, A McMichael, V Appay |
Immunology Letters | 2001 |
New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers
R Kaul, S L Rowland-Jones, J Kimani, K Fowke, T Dong, P Kiama, J Rutherford, E Njagi, F Mwangi, T Rostron, J Onyango, J Oyugi, K S MacDonald, J J Bwayo, F A Plummer |
Immunology Letters | 2001 |
Relative Dominance of Epitope-Specific Cytotoxic T-Lymphocyte Responses in Human Immunodeficiency Virus Type 1-Infected Persons with Shared HLA Alleles
CL Day, AK Shea, MA Altfeld, DP Olson, SP Buchbinder, FM Hecht, ES Rosenberg, BD Walker, SA Kalams |
Journal of virology | 2001 |
Induction of Potent Human Immunodeficiency Virus Type 1-Specific T-Cell-Restricted Immunity by Genetically Modified Dendritic Cells
J Lisziewicz, DI Gabrilovich, G Varga, J Xu, PD Greenberg, SK Arya, M Bosch, JP Behr, F Lori |
Journal of virology | 2001 |
Route of Simian Immunodeficiency Virus Inoculation Determines the Complexity but Not the Identity of Viral Variant Populations That Infect Rhesus Macaques
JL Greenier, CJ Miller, D Lu, PJ Dailey, FX Lu, KJ Kunstman, SM Wolinsky, ML Marthas |
Journal of virology | 2001 |
Evolutionary and immunological implications of contemporary HIV-1 variation
B Korber, B Gaschen, K Yusim, R Thakallapally, C Kesmir, V Detours |
British Medical Bulletin | 2001 |
HIV-1 transmission and acute HIV-1 infection
P Hansasuta, SL Rowland-Jones |
British Medical Bulletin | 2001 |
Polymorphisms in HLA Class I Genes Associated with both Favorable Prognosis of Human Immunodeficiency Virus (HIV) Type 1 Infection and Positive Cytotoxic T-Lymphocyte Responses to ALVAC-HIV Recombinant Canarypox Vaccines
RA Kaslow, C Rivers, J Tang, TJ Bender, PA Goepfert, RE Habib, K Weinhold, MJ Mulligan |
Journal of virology | 2001 |
CD8 + Lymphocytes from Simian Immunodeficiency Virus-Infected Rhesus Macaques Recognize 14 Different Epitopes Bound by the Major Histocompatibility Complex Class I Molecule Mamu-A*01: Implications for Vaccine Design and Testing
TM Allen, BR Mothé, J Sidney, P Jing, JL Dzuris, ME Liebl, TU Vogel, DH O'Connor, X Wang, MC Wussow, JA Thomson, JD Altman, DI Watkins, A Sette |
Journal of virology | 2001 |